Journals / European Journal of Breast Health / 2021 / Cilt: 17 - Sayı: 3

Results of Excision of Unknown Papillary NeoplasmsDetected on Core Biopsy

Pages
258–264
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The lesions should be adequately sampled.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to find out valuable parameters that predict the nature of breast papillary lesions before excision, and we compared our results with those in the literature.Materials and Methods: We reviewed the medical records and pathology slides of patients diagnosed with papillary neoplasm after undergoing a coreneedle biopsy between 2010 and 2020, who, subsequently, underwent surgical excision in a single tertiary care institution.
📊
Key Findings & Data:The core biopsy results and pathology results of excision materials were compared with the radiological, pathological, and demographic findings.Results: A total of 51 patients were included in the study.
💡
Conclusion & Impact:The lesions should be adequately sampled.
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to find out valuable parameters that predict the nature of breast papillary lesions before excision, and we compared our results with those in the literature.Materials and Methods: We reviewed the medical records and pathology slides of patients diagnosed with papillary neoplasm after undergoing a coreneedle biopsy between 2010 and 2020, who, subsequently, underwent surgical excision in a single tertiary care institution. The core biopsy results and pathology results of excision materials were compared with the radiological, pathological, and demographic findings.Results: A total of 51 patients were included in the study. According to the excision results, the patients were divided into two groups: the atypical group, which included 20 patients (39.3%), and the benign group, which included 31 patients (61.7%). The results of the core biopsy showed that the loss of myoepithelial cell layer was identified in 18 patients in the atypical group, while it was present in all patients in the benign group. Tumor sizes were larger and patient ages were older in the atypical group compared with the benign group. No significant difference was found between atypical and benign groups in terms of breast imaging-reporting and data system (BI-RADS) classification and location (right vs left; central vs peripheral). The upgrade rate was between 0% and 16% in literature, while it was 4% in our study.Conclusion: There is no consensus on whether patients diagnosed with papillary neoplasia as a result of core biopsy will undergo excision. According to our results, patients with following criteria should have their lesions excised: those who are advanced in age, those who are diagnosed with a papillary lesion as a result of core biopsies with loss of myoepithelial cell layer, and those who are diagnosed with large-sized lesions without loss of myoepithelial cell layer. Patients diagnosed with small-sized lesions without loss of myoepithelial cell layer and who are young in age are to be followed up without the need for lesion excision. The lesions should be adequately sampled.

🔖

Cite This Article

ÜNLÜ, Y., BAYRAMOĞLU, Z., YILDIRIM, E. N. Ö., ALTUNKESER, A., ERYILMAZ, M. A., AKSOY, N., KILINÇ, A. N. U., BARAN, N. (2022). Results of Excision of Unknown Papillary NeoplasmsDetected on Core Biopsy. European Journal of Breast Health, Cilt: 17 - Sayı: 3, 258–264. https://ajindex.com/articles/510688

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Brogi E, Horii R, Mac Grogan G, Rakha EA, Troxelli ML, Tse G, et al. Papillary neoplasms: breast tumours, WHO classification of tumours. 5th ed. WHO Classification Editorial Board, 2019: 49. [Crossref] 2. Cheng TY, Chen CM, Lee MY, Lin KJ, Hung CF, Yang PS, et al. Risk factors associated with conversion from nonmalignant to malignant diagnosis after surgical excision of breast papillary lesions. Ann Surg Oncol. 2009
  2. (PMID: 19641969) [Crossref] 3. Rizzo M, Linebarger J, Lowe MC, Pan L, Gabram SG, Vasquez L, et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical followup. Jx Am Coll Surg 2012
  3. (PMID: 22244207) [Crossref] 4. Youk JH, Kim EK, Kwak JY, Son EJ, Park BW, Kim SI. Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy. Radiology 2011
  4. (PMID: 20971773) [Crossref] 5. Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol 2013
  5. (PMID: 22878621) [Crossref] 6. Nayak A, Carkaci S, Gilcrease MZ, Liu P, Middleton LP, Bassett Jr RL, et al. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer 2013
  6. (PMID: 24119786 [Crossref] 7. Hong YR, Song BJ, Jung SS, Kang BJ, Kim SH, Chae BJ. Predictive factors for upgrading patients with benign breast papillary lesions using a core needle biopsy. J Breast Cancer 2016
  7. (PMID: 28053629) [Crossref] 8. Wiratkapun C, Keeratitragoon T, Lertsithichai P, Chanplakorn N. Upgrading rate of papillary breast lesions diagnosed by core-needle biopsy. Diagn Interv Radiol 2013
  8. (PMID: 23748032) [Crossref] 9. Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol 2004
  9. (PMID: 15362376) [Crossref] 10. Pathmanathan N, Albertini AF, Provan PJ, Milliken JS, Salisbury EL, Bilous AM, et al. Diagnostic evaluation of papillary lesions of the breast on core biopsy. Mod Pathol 2010
  10. (PMID: 20473278) [Crossref] 11. Yang Y, Suzuki K, Abe E, Li C, Uno M, Akiyama F, et al. The significance of combined CK5/6 and p63 immunoh